Aspirin coating may reduce drug's heart benefits, study finds

A common aspirin coating may reduce the drug's benefits in preventing cardiovascular disease, University of Pennsylvania researchers wrote the journal Circulation. Physicians and drug researchers have said up to 40% of patients can be aspirin-resistant, but the study could not find one case of resistance among 400 people tested.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health